 |
PALO ALTO, Calif., April 27, 2023 /PRNewswire/ -- Saitama Medical University Hospital and Healint launched one of the world's first clinical studies titled "Verification of Headache AI diagnosis by using Electronic Headache Diary in Telemedicine". About 20 renowned headache specialists participated from multiple locations, mainly in the Tokyo metropolitan area to conduct this research together. From the end of April, they plan to recruit more patients.
Although there are currently 30 million chronic headache patients in Japan, the diagnosis and treatment rate of migraine among non-headache specialists is less than 20%. Under these circumstances, there is an urgent need to develop tools to support the diagnosis of headache. The study is expected to validate how the AI can support a broad range of doctors in diagnosing patients, and each of their attacks, in order to select treatments as well as to potentially identify the symptom patterns associated with fatal conditions earlier.
This study will lead to a breakthrough in opening the path to precision medicine and diagnosing the condition of migraine, which affects more than 36 million people in the US alone, and hundreds of millions more worldwide. In the future, it will also enable doctors to better diagnose patients with migraine and other related conditions, as well as allow them to select treatments based on accurate diagnosis. The study has been conducted in 2023 and the results are expected to be published soon after completion.
The AI used in this study is powered by Healint's proprietary technology, an end-to-end machine learning platform for medical and healthcare applications. Healint's platform is called Migraine Buddy, and is the world's most used headache tracking application. The platform uses artificial intelligence to detect patterns from large datasets of patients' data. Over the past 10 years, Migraine Buddy has gained more than 3.5 million users worldwide, has trained AI with their detailed headache and migraine attack records, and has accumulated a large dataset to date from which it is possible to detect patterns.
About Healint
Healint Pte Ltd is a leading healthcare technology company transforming how patients manage chronic diseases related to the brain and the immune system. Healint puts healthcare in the hands of patients and empowers them to be active in the participation in clinical trials and real-world studies. Healint's virtual clinical trial platform delivers reliable, high-quality data, shortens study timeline and achieves big cost-savings.
Find out more at https://healint.com/
Healint's Migraine Buddy application with over 3.5 million engaged users:
https://migrainebuddy.com/
Contact
Name: Noriko Hanada
Email: noriko.hanada@healint.com
Contact number: +65 8451 8740
Designation: Vice President Business Development
